COVID-19 Lock-Down: India Pharma Manufacturing Limps Along Amid Challenges

Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.

Cogs
Drug Manufacturing Under Strain In India • Source: Shutterstock

Pharma manufacturing continues to come under pressure in India as the country passes the half-way mark in a 21-day, country-wide lock-down enforced as part of measures to contain the spread of COVID-19.

While the pharma industry and Indian government are working in close co-ordination to address the challenges, top companies have provided...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip